can show minor reactions for
those reactive to sulphur.
He explained that the reaction for those sulphur reactive who took NBMI might be the same as if they ate an excess of thiol containing compounds. The symptoms would be a small rash on the arms or chest areas that goes away quickly after ingestion stops.
The fix for those sensitive would be to reduce the dosage to 1/4 of the recommended dosage for several days and then slowly increasing the amount until the rash symptoms stop completely. Also, taking a molybdenum supplement has helped some.
He explains, “The basic biochemical issue is that there is a decreased ability to convert the toxic sulfite to the non-toxic sulfate by the molybdenum requiring enzyme sulfite oxidase. Molybdenum supplementation helps in most cases, but it takes a few days to maximize the activity of the sulfite oxidase. As an aside, autistics seem to have a 50 fold higher level of sulfite when compared to control children in a research project done by Dr. Rosemary Waring in England.”
NBMI is currently in FDA trials for use primarily as a drug to detox mercury and other heavy metals. It was previously used successfully and sold as a supplement. Although there have been many name changes, including OSR and Emeramide, the product is now known as NBMI by the parent company Emeramed.
The final release of NBMI promises to be the first real hope for those metals poisoned. It offers quick, efficient and effective results without the harsh side effects that the current options offer. To access NBMI during trials see the link below.